S1692 Post-Transplant Exposure to GLP-1RA Therapy May Be Associated With Improved Survival in Liver Transplant Recipients With Type II Diabetes Mellitus at 5 Years Post-Transplant Or Longer
Sudharshan Achalu(Palo Alto University), Paul Y. Kwo(Palo Alto University), Mai Sedki(Stanford University), Saurabh Gombar(Stanford University), Richie Manikat(Stanford University), Seren M. Gedallovich(Stanford University)
Cited by 1
Related Papers
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
|Gastroenterology|2015|799
Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1
|Gastroenterology|2016|305
Interferon‐free therapy for genotype 1 hepatitis C in liver transplant recipients: Real‐world experience from the hepatitis C therapeutic registry and research network
|Liver Transplantation|2015|105
Current epidemiology of chronic liver disease
|Gastroenterology report|2023|56